Get started
Author

Enrique Conde

Observed names: Conde-Gallastegi, Enrique, E. Conde, Enrique Conde-Gallastegi
ORCID: 0000-0002-3587-1506
Observed ORCID: 0000-0002-3587-1506
OpenAlex ID: A5057904579
Expansion of Tumor-Infiltrating CD8+ T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy
2017 · Sarita M. Fernandez-Poma, Diego Salas-Benito, et al. · Cancer Research · 144
Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants
2021 · Enrique Conde, Enric Vercher, et al. · Journal for ImmunoTherapy of Cancer · 67
PDF
Microglia and astrocyte activation is region‐dependent in the α‐synuclein mouse model of Parkinson's disease
2022 · Leyre Basurco, Miguel Angel Abellanas, et al. · Glia · 66
Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
2022 · Celia Martín-Otal, Aritz Lasarte-Cia, et al. · Journal for ImmunoTherapy of Cancer · 48
PDF
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies
2025 · Felipe Galvez-Cancino, Mariela Navarrete, et al. · Immunity · 43
Inflammation and immunity in ovarian cancer
2020 · Diego Salas-Benito, Enric Vercher, et al. · European Journal of Cancer Supplements · 36
PDF
TCR-induced FOXP3 expression by CD8+ T cells impairs their anti-tumor activity
2021 · Teresa Lozano, Enrique Conde, et al. · Cancer Letters · 24
The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes
2021 · Diego Salas-Benito, Enrique Conde, et al. · British Journal of Cancer · 23
PDF
FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma
2022 · Enrique Conde, Noelia Casares, et al. · Molecular Therapy · 21
Nigrostriatal degeneration determines dynamics of glial inflammatory and phagocytic activity
2024 · Leyre Ayerra, Miguel Angel Abellanas, et al. · Journal of Neuroinflammation · 12
PDF
Human T cells engineered with an HLA-A2-restricted murine T-cell receptor targeting glypican 3 effectively control human hepatocellular carcinoma in mice
2024 · Enric Vercher, Ángela Covo-Vergara, et al. · Hepatology · 11
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies
2025 · Felipe Galvez-Cancino, Mariela Navarrete, et al. · Immunity · 6
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
2022 · David Repáraz, Marta Ruiz, et al. · Frontiers in Immunology · 5
The mutational load and a T-cell inflamed tumor phenotype identify ovarian cancer patients rendering tumor-reactive T cells from PD-1+ tumor-infiltrating lymphocytes
2020 · Diego Salas-Benito, Enrique Conde, et al. · 1
PDF
Stromal remodeling and neoantigen clonality as used to evaluate benefit from SIRT–nivolumab in HCC.
2026 · Josepmaria Argemi, Sandra Hervas-Stubbs, et al. · Journal of Clinical Oncology
Abstract 1523: Galectin-3 blockade reprograms the tumor microenvironment and improves CAR T-cell therapy in pediatric cancers
2026 · Enrique Conde-Gallastegi, Karin Straathof, et al. · Cancer Research
Preselecting tumour-infiltrating lymphocyte subsets to implement adoptive immunotherapy in ovarian cancer
2019 · D. Salas-Benito, C. De Andrea, et al. · Annals of Oncology
JAK2 in the Diagnosis and Treatment of Lymphoid Malignancies: A Review of the Literature.
2016 · Lakshan N Fonseka, Beatriz Germán, et al. · PubMed
Works count: 19
Citation count: 507
H-index: 11
I10-index: 11
Year
Topic
Type